Category list : Anti-arrhythmia agents
Arrhythmia NSF chapter launched Subscription
A chapter on arrhythmias and sudden cardiac death has been added to
Arrhythmia is a term which refers to any change in the normal rate or rhythm of the heart. Arrhythmias occur secondary to alterations in the generation or conduction of electrical activity within the myocardium. In order to understand them fully it is necessary first to know a little about how the heart’s normal rate and rhythm are maintained.
The goal of treatment for patients with arrhythmias is preferably to return the heart to sinus rhythm, or failing that, at least to stabilise the rate. The second article in this month’s special feature reviews the pharmacological and non-pharmacological treatment options available
Atrial fibrillation guideline updates Subscription
How the latest clinical guidelines change the management of a cardiac arrhythmia affecting 1% of adults in the UK.
Heart disease (8) Arrhythmias: Part 1 Subscription
An arrhythmia is any abnormality in heart rate (HR) or rhythm. Some arrhythmias are benign, but others can cause sudden death. It is estimated that 5.3 per cent of people are managing an arrhythmia at any given time. Many arrhythmias remain undiagnosed.
Heart disease (8) Arrhythmias: Part 2 Subscription
The first part of this article (PJ, 20 September, pp368–70) outlined the mechanisms controlling normal heart rate and rhythm, and the management of bradycardias and some atrial tachycardias. This second part focuses on the management of atrial fibrillation and ventricular tachycardia.
Spotlight on medicines: Dronedarone Subscription
Medicines used to treat atrial fibrillation can cause various side effects. Dronedarone, the most recent antiarrhythmic drug to become available, is well tolerated. This article looks at its place in therapy